| Isotretinoin | Approved Investigational | CPD | 1362 |
downregulated | Isotretinoin results in decreased expression of CPD mRNA | 17q11.2 | |
| Isotretinoin | Approved Investigational | CPT2 | 1376 |
downregulated | Isotretinoin results in decreased expression of CPT2 mRNA | 1p32.3 | |
| Isotretinoin | Approved Investigational | CRABP2 | 1382 |
upregulated | Isotretinoin results in increased expression of CRABP2 mRNA | 1q23.1 | |
| Isotretinoin | Approved Investigational | CRAT | 1384 |
downregulated | Isotretinoin results in decreased expression of CRAT mRNA | 9q34.11 | |
| Isotretinoin | Approved Investigational | CRIPT | 9419 |
downregulated | Isotretinoin results in decreased expression of CRIPT mRNA | 2p21 | |
| Isotretinoin | Approved Investigational | CRTC3 | 64784 |
upregulated | Isotretinoin results in increased expression of CRTC3 mRNA | 15q26.1 | |
| Isotretinoin | Approved Investigational | CSF1R | 1436 |
upregulated | Isotretinoin results in increased expression of CSF1R mRNA | 5q32 | |
| Isotretinoin | Approved Investigational | CST3 | 1471 |
upregulated | Isotretinoin results in increased expression of CST3 mRNA | 20p11.21 | |
| Isotretinoin | Approved Investigational | CSTB | 1476 |
downregulated | Isotretinoin results in decreased expression of CSTB mRNA | 21q22.3 | |
| Isotretinoin | Approved Investigational | CTH | 1491 |
downregulated | Isotretinoin results in decreased expression of CTH mRNA | 1p31.1 | |
| Isotretinoin | Approved Investigational | CTTN | 2017 |
downregulated | Isotretinoin results in decreased expression of CTTN mRNA | 11q13.3 | |
| Isotretinoin | Approved Investigational | CUX2 | 23316 |
downregulated | Isotretinoin results in decreased expression of CUX2 mRNA | 12q24.11-q24.12 | |
| Isotretinoin | Approved Investigational | CXCL1 | 2919 |
downregulated | Isotretinoin results in decreased expression of CXCL1 mRNA | 4q13.3 | |
| Isotretinoin | Approved Investigational | CXCL10 | 3627 |
downregulated | Isotretinoin results in decreased expression of CXCL10 mRNA | 4q21.1 | |
| Isotretinoin | Approved Investigational | CXCL12 | 6387 |
upregulated | Isotretinoin results in increased expression of CXCL12 mRNA | 10q11.21 | |
| Isotretinoin | Approved Investigational | CYB5A | 1528 |
downregulated | Isotretinoin results in decreased expression of CYB5A mRNA | 18q22.3 | |
| Isotretinoin | Approved Investigational | CYP26A1 | 1592 |
upregulated | Isotretinoin results in increased expression of CYP26A1 mRNA | 10q23.33 | |
| Isotretinoin | Approved Investigational | CYP26B1 | 56603 |
upregulated | Isotretinoin results in increased expression of CYP26B1 mRNA | 2p13.2 | |
| Isotretinoin | Approved Investigational | CYP27A1 | 1593 |
downregulated | Isotretinoin results in decreased expression of CYP27A1 mRNA | 2q35 | |
| Isotretinoin | Approved Investigational | CYP3A4 | 1576 |
upregulated | [Isotretinoin results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA | 7q22.1 | |
| Isotretinoin | Approved Investigational | CYP3A7 | 1551 |
downregulated | Isotretinoin results in decreased expression of CYP3A7 mRNA | 7q22.1 | |
| Isotretinoin | Approved Investigational | CYP4A11 | 1579 |
downregulated | Isotretinoin results in decreased expression of CYP4A11 mRNA | 1p33 | |
| Isotretinoin | Approved Investigational | CYP4F2 | 8529 |
downregulated | Isotretinoin results in decreased expression of CYP4F2 mRNA | 19p13.12 | |
| Isotretinoin | Approved Investigational | CYP4F3 | 4051 |
downregulated | Isotretinoin results in decreased expression of CYP4F3 mRNA | 19p13.12 | |
| Isotretinoin | Approved Investigational | CYP4F8 | 11283 |
downregulated | Isotretinoin results in decreased expression of CYP4F8 mRNA | 19p13.12 | |